- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2220EUR$2,490USD£1,919GBP
- Report
- March 2025
- 200 Pages
Global
From €2220EUR$2,490USD£1,919GBP
- Report
- July 2023
- 220 Pages
Global
From €1774EUR$1,990USD£1,534GBP
- Report
- March 2024
- 200 Pages
Global
From €3699EUR$4,150USD£3,199GBP
- Report
- January 2024
- 200 Pages
Global
From €3699EUR$4,150USD£3,199GBP
- Report
- August 2023
- 145 Pages
Global
From €2808EUR$3,150USD£2,428GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2674EUR$3,000USD£2,313GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1114EUR$1,250USD£964GBP
- Report
- February 2024
- 70 Pages
United States
From €4234EUR$4,750USD£3,662GBP
- Report
- February 2024
- 70 Pages
Oman
From €4234EUR$4,750USD£3,662GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4234EUR$4,750USD£3,662GBP
- Report
- July 2025
- 200 Pages
India
From €2486EUR$2,789USD£2,150GBP
- Report
- August 2024
- 150 Pages
Global
From €2486EUR$2,789USD£2,150GBP
- Report
- March 2026
- 136 Pages
France
From €3565EUR$3,999USD£3,083GBP
- Report
- May 2024
- 139 Pages
Global
From €3565EUR$3,999USD£3,083GBP
- Report
- May 2024
- 128 Pages
Global
From €3565EUR$3,999USD£3,083GBP
- Report
- May 2024
- 140 Pages
Global
From €3565EUR$3,999USD£3,083GBP
- Report
- January 2026
- 70 Pages
Indonesia
From €4234EUR$4,750USD£3,662GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4234EUR$4,750USD£3,662GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4234EUR$4,750USD£3,662GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more